Bentham Science Publishers logo

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Drug Targets-CNS & Neurological Disorders is now published as CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders).

Publisher: Bentham Science Publishers

Related content
Volume 3, Number 5, October 2004

< previous issue | all issues | next issue >

Book review

Review article

Gut Hormones as Peripheral Anti Obesity Targets
pp. 379-388(10)
Authors: Small, Caroline J.; Bloom, Stephen R.

Exercise in a Pill: Feasibility of Energy Expenditure Targets
pp. 389-409(21)
Author: Himms-Hagen, J.

Lipid Metabolism and Nutrient Partitioning Strategies
pp. 411-430(20)
Authors: Morris, A. M.; Calsbeek, D. J.; Eckel, R. H.

Metabolic Syndrome Targets
pp. 431-439(9)
Author: Smith, Steven R.

< previous issue | all issues | next issue >


Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page